Marcello Arca Selected Research

Marcello Arca Research Topics

Disease

26	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 09/2005
25	Atherosclerosis 11/2023 - 01/2003
18	Hypercholesterolemia 11/2022 - 11/2002
17	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 11/2023 - 01/2008
16	Homozygous Familial Hypercholesterolemia 01/2024 - 11/2002
12	Insulin Resistance 11/2022 - 03/2002
11	Dyslipidemias (Dyslipidemia) 11/2022 - 11/2007
10	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2003
9	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2022 - 11/2002
8	Pancreatitis 04/2024 - 01/2018
8	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 04/2024 - 07/2018
7	Coronary Disease (Coronary Heart Disease) 01/2024 - 01/2007
7	Costello Syndrome 05/2023 - 01/2018
7	Inborn Genetic Diseases (Disease, Hereditary) 05/2023 - 06/2014
6	2 Familial Hypobetalipoproteinemia 01/2023 - 12/2013
6	Type 2 Diabetes Mellitus (MODY) 11/2022 - 03/2002
6	Myocardial Infarction 01/2020 - 05/2004
5	Stroke (Strokes) 02/2021 - 05/2004
5	Diabetes Mellitus 01/2018 - 01/2007
5	Atherosclerotic Plaque (Atheroma) 05/2017 - 05/2004
5	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 10/2015 - 10/2002
4	Hypertriglyceridemia 12/2022 - 04/2011
4	Non-alcoholic Fatty Liver Disease 01/2022 - 11/2017
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 01/2007
4	Acute Coronary Syndrome 01/2018 - 01/2007
4	Muscular Diseases (Myopathy) 12/2017 - 12/2008
4	Hyperlipidemias (Hyperlipidemia) 01/2016 - 10/2002
4	Neutral Lipid Storage Disease with Myopathy 09/2013 - 12/2008
3	Obesity 01/2022 - 03/2002
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 02/2021 - 01/2007
3	Infections 01/2021 - 01/2007
3	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 09/2017 - 01/2017
3	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 01/2017 - 09/2005
2	Hypertension (High Blood Pressure) 01/2024 - 01/2007
2	Fibrosis (Cirrhosis) 01/2023 - 11/2017
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 12/2019
2	Myalgia 11/2022 - 01/2011
2	Abdominal Pain (Pain, Abdominal) 10/2022 - 07/2018
2	Genetic Risk Score 01/2022 - 01/2021
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 01/2020
2	Fatty Liver 01/2022 - 09/2017
2	Overweight 01/2021 - 12/2004
2	Coronary Stenosis (Coronary Artery Stenosis) 01/2021 - 04/2008
2	Inflammation (Inflammations) 01/2020 - 12/2010
2	Injection Site Reaction 01/2020 - 01/2019
2	Tangier Disease 01/2019 - 01/2016
2	Ichthyosis (Xeroderma) 12/2017 - 05/2008
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2007 - 01/2007
2	Ischemic Stroke 01/2007 - 05/2004

Drug/Important Bio-Agent (IBA)

45	LipidsIBA 01/2024 - 10/2002
36	oxidized low density lipoproteinIBA 01/2024 - 11/2002
30	LDL CholesterolIBA 01/2024 - 01/2007
24	Triglycerides (Triacylglycerol)IBA 04/2024 - 11/2007
23	CholesterolIBA 01/2023 - 01/2007
16	Lipoproteins (Lipoprotein)IBA 01/2023 - 02/2015
13	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2023 - 01/2007
9	HDL CholesterolIBA 01/2024 - 11/2007
9	BMS201038IBA 01/2023 - 01/2017
8	Proteins (Proteins, Gene)FDA Link 11/2022 - 03/2004
7	ISIS 304801IBA 10/2023 - 07/2018
7	Apolipoproteins B (ApoB)IBA 01/2023 - 09/2003
7	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2020 - 10/2002
6	Insulin (Novolin)FDA Link 01/2022 - 03/2002
6	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 11/2002
6	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 10/2002
6	Lipase (Acid Lipase)FDA Link 09/2013 - 09/2003
6	Atorvastatin (Lipitor)FDA Link 11/2007 - 11/2004
5	Lipoprotein(a)IBA 10/2023 - 01/2021
5	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 12/2004
5	EnzymesIBA 01/2021 - 05/2008
4	Apolipoprotein C-IIIIBA 04/2024 - 07/2018
4	PCSK9 InhibitorsIBA 11/2023 - 01/2017
4	ApolipoproteinsIBA 12/2022 - 01/2017
4	HDL LipoproteinsIBA 12/2020 - 09/2005
4	LDL Receptors (LDL Receptor)IBA 11/2020 - 10/2006
3	Antihypertensive Agents (Antihypertensives)IBA 01/2024 - 01/2007
3	omega-Chloroacetophenone (Mace)IBA 01/2024 - 04/2008
3	Transaminases (Aminotransferases)IBA 01/2023 - 01/2011
3	Proprotein Convertase 9IBA 07/2021 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2007
3	Trinitrotoluene (TNT)IBA 01/2007 - 01/2007
3	Pravastatin (Pravachol)FDA LinkGeneric 01/2007 - 01/2007
2	SubtilisinIBA 11/2023 - 01/2020
2	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 11/2023 - 01/2020
2	alirocumabIBA 11/2023 - 11/2022
2	ChylomicronsIBA 12/2022 - 02/2015
2	Blood Glucose (Blood Sugar)IBA 11/2022 - 04/2011
2	Nonesterified Fatty Acids (NEFA)IBA 11/2022 - 07/2013
2	CytokinesIBA 09/2021 - 01/2003
2	Ezetimibe (Zetia)FDA Link 07/2021 - 01/2020
2	CalciumIBA 01/2021 - 01/2021
2	Phospholipases (Phospholipase)IBA 11/2017 - 12/2012
2	Apolipoproteins E (ApoE)IBA 10/2017 - 09/2003
2	Apolipoprotein B-48IBA 01/2016 - 02/2015
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2010 - 05/2004
2	DNA (Deoxyribonucleic Acid)IBA 01/2008 - 09/2005
2	Fenofibrate (CiL)FDA LinkGeneric 11/2007 - 03/2007

Therapy/Procedure

27	Therapeutics 04/2024 - 01/2007
6	Secondary Prevention 02/2021 - 01/2007
3	Blood Component Removal (Apheresis) 01/2022 - 01/2017